Experimentally induced ischaemic pain in healthy humans is attenuated by the adenosine receptor antagonist theophylline.
D000328:Adult; D001794:Blood Pressure / Q000502:physiology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007511:Ischemia / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000098:blood supply* / Q000503:physiopathology; D010146:Pain / Q000517:prevention & control*; D010147:Pain Measurement / Q000379:methods; D058915:Purinergic P1 Receptor Antagonists; D013806:Theophylline / Q000008:administration & dosage* / Q000009:adverse effects; D014111:Tourniquets; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects
D058915:Purinergic P1 Receptor Antagonists; D014665:Vasodilator Agents; D013806:Theophylline